Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.475 AUD | +1.06% | +6.74% | +37.68% |
May. 17 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
May. 15 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
Evolution of the average Target Price on Immutep Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Immutep Limited
Capital One Securities | |
Canaccord Genuity | |
Baird | |
Maxim | |
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- IMM Stock
- Consensus Immutep Limited